Lisanti Capital Growth, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 270 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$7,630,000
-66.9%
130,873
-56.7%
1.04%
-60.0%
Q1 2022$23,080,000
+209.4%
302,413
+143.9%
2.59%
+140.2%
Q4 2021$7,460,000
+317.2%
123,985
+288.4%
1.08%
+308.7%
Q3 2021$1,788,000
+38.0%
31,925
+49.4%
0.26%
+65.0%
Q2 2021$1,296,000
-89.9%
21,365
-88.3%
0.16%
-90.3%
Q1 2021$12,834,000
+26.7%
183,105
+8.7%
1.65%
-12.2%
Q3 2020$10,129,000
+14.6%
168,482
+0.1%
1.88%
+4.1%
Q2 2020$8,835,000
+142.5%
168,388
+54.9%
1.80%
+49.7%
Q1 2020$3,644,000
-22.0%
108,679
+5.4%
1.20%
-2.9%
Q4 2019$4,673,000
+28.7%
103,149
+8.2%
1.24%
+4.6%
Q3 2019$3,631,000
-29.6%
95,370
-19.6%
1.18%
-29.4%
Q2 2019$5,159,000
+88.2%
118,620
+64.7%
1.68%
+72.7%
Q1 2019$2,741,000
-38.3%
72,005
-30.2%
0.97%
-45.8%
Q4 2018$4,439,000
+49.0%
103,190
+70.2%
1.79%
+73.2%
Q3 2018$2,979,000
+273.8%
60,615
+263.0%
1.04%
+94.9%
Q2 2017$797,000
+69.2%
16,700
+61.8%
0.53%
-21.2%
Q1 2017$471,000
-74.5%
10,320
-57.1%
0.67%
-65.2%
Q4 2015$1,846,000
-60.5%
24,035
-50.2%
1.94%
-17.6%
Q3 2014$4,679,000
+0.8%
48,280
-4.5%
2.35%
+13.2%
Q2 2014$4,642,000
+29.1%
50,530
-1.6%
2.08%
+33.9%
Q1 2014$3,595,000
+20.3%
51,365
-1.2%
1.55%
+23.4%
Q4 2013$2,989,000
-13.4%
51,995
-27.5%
1.26%
-20.0%
Q3 2013$3,450,000
+238.6%
71,760
+138.9%
1.57%
+222.1%
Q2 2013$1,019,00030,0350.49%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders